NCT00154739View on ClinicalTrials.gov

Gemcitabine/Cisplatin Versus Gemcitabine/Epirubicin for Non-Small Cell Lung Cancer (NSCLC)

PHASE2CompletedINTERVENTIONAL
Enrollment

86

Participants

Timeline

Start Date

October 31, 1998

Primary Completion Date

July 31, 2005

Study Completion Date

July 31, 2005

Conditions
Non-Small Cell Lung Cancer
Interventions
DRUG

Gemcitabine

DRUG

Cisplatin

DRUG

Epirubicin

Trial Locations (1)

112

Department of Oncology, National Taiwan University Hospital, Taipei

All Listed Sponsors
lead

National Taiwan University Hospital

OTHER

NCT00154739 - Gemcitabine/Cisplatin Versus Gemcitabine/Epirubicin for Non-Small Cell Lung Cancer (NSCLC) | Biotech Hunter | Biotech Hunter